Literature DB >> 21624366

Innate immune responses in central nervous system inflammation.

Bente Finsen1, Trevor Owens.   

Abstract

In autoimmune diseases of the central nervous system (CNS), innate glial cell responses play a key role in determining the outcome of leukocyte infiltration. Access of leukocytes is controlled via complex interactions with glial components of the blood-brain barrier that include angiotensin II receptors on astrocytes and immunoregulatory mediators such as Type I interferons which regulate cellular traffic. Myeloid cells at the blood-brain barrier present antigen to T cells and influence cytokine effector function. Myelin-specific T cells interact with microglia and promote differentiation of oligodendrocyte precursor cells in response to axonal injury. These innate responses offer potential targets for immunomodulatory therapy.
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21624366     DOI: 10.1016/j.febslet.2011.05.030

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  20 in total

Review 1.  Metabolic Dysfunction in Parkinson's Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism.

Authors:  Annadurai Anandhan; Maria S Jacome; Shulei Lei; Pablo Hernandez-Franco; Aglaia Pappa; Mihalis I Panayiotidis; Robert Powers; Rodrigo Franco
Journal:  Brain Res Bull       Date:  2017-03-21       Impact factor: 4.077

2.  Lack of formyl peptide receptor 1 and 2 leads to more severe inflammation and higher mortality in mice with of pneumococcal meningitis.

Authors:  Sandra Oldekamp; Sebastian Pscheidl; Eugenia Kress; Oliver Soehnlein; Sandra Jansen; Thomas Pufe; Ji Ming Wang; Simone C Tauber; Lars-Ove Brandenburg
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

3.  Innate immune activation in the pathogenesis of a murine model of globoid cell leukodystrophy.

Authors:  Eric R Snook; Jeanne M Fisher-Perkins; Hope A Sansing; Kim M Lee; Xavier Alvarez; Andrew G MacLean; Karin E Peterson; Andrew A Lackner; Bruce A Bunnell
Journal:  Am J Pathol       Date:  2013-12-04       Impact factor: 4.307

Review 4.  Mitochondrial dysfunction in glial cells: Implications for neuronal homeostasis and survival.

Authors:  Jordan Rose; Christian Brian; Jade Woods; Aglaia Pappa; Mihalis I Panayiotidis; Robert Powers; Rodrigo Franco
Journal:  Toxicology       Date:  2017-06-26       Impact factor: 4.221

5.  Effects of therapeutic hypothermia on inflammasome signaling after traumatic brain injury.

Authors:  Satoshi Tomura; Juan Pablo de Rivero Vaccari; Robert W Keane; Helen M Bramlett; W Dalton Dietrich
Journal:  J Cereb Blood Flow Metab       Date:  2012-07-11       Impact factor: 6.200

Review 6.  Infection risk in patients on multiple sclerosis therapeutics.

Authors:  Eric M Williamson; Joseph R Berger
Journal:  CNS Drugs       Date:  2015-03       Impact factor: 5.749

7.  An association between mitochondria and microglia effector function. What do we think we know?

Authors:  G Jean Harry; Gabrielle Childers; Sahana Giridharan; Irisyunuel Lopez Hernandes
Journal:  Neuroimmunol Neuroinflamm       Date:  2020-06-16

Review 8.  Neuroimmune communication in hypertension and obesity: a new therapeutic angle?

Authors:  Annette D de Kloet; Eric G Krause; Peng D Shi; Jasenka Zubcevic; Mohan K Raizada; Colin Sumners
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

9.  Gene Therapy for the Treatment of Neurological Disorders: Central Nervous System Neoplasms.

Authors:  Neha Kamran; Marianela Candolfi; Gregory J Baker; Mariela Moreno Ayala; Marta Dzaman; Pedro R Lowenstein; Maria G Castro
Journal:  Methods Mol Biol       Date:  2016

10.  Challenging the role of adaptive immunity in neurotrauma: Rag1(-/-) mice lacking mature B and T cells do not show neuroprotection after closed head injury.

Authors:  Sebastian Weckbach; Miriam Neher; Justin T Losacco; Ashley L Bolden; Liudmila Kulik; Michael A Flierl; Scott E Bell; V Michael Holers; Philip F Stahel
Journal:  J Neurotrauma       Date:  2012-04-10       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.